Lane RM

References (6)

Title : Onset of Alzheimer disease in apolipoprotein sigma4 carriers is earlier in butyrylcholinesterase K variant carriers - Lane_2024_BMC.Neurol_24_116
Author(s) : Lane RM , Darreh-Shori T , Junge C , Li D , Yang Q , Edwards AL , Graham DL , Moore K , Mummery CJ
Ref : BMC Neurol , 24 :116 , 2024
Abstract : Lane_2024_BMC.Neurol_24_116
ESTHER : Lane_2024_BMC.Neurol_24_116
PubMedSearch : Lane_2024_BMC.Neurol_24_116
PubMedID: 38594621
Gene_locus related to this paper: human-BCHE

Title : Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value - Lane_2015_J.Alzheimers.Dis_44_1039
Author(s) : Lane RM , Darreh-Shori T
Ref : J Alzheimers Dis , 44 :1039 , 2015
Abstract : Lane_2015_J.Alzheimers.Dis_44_1039
ESTHER : Lane_2015_J.Alzheimers.Dis_44_1039
PubMedSearch : Lane_2015_J.Alzheimers.Dis_44_1039
PubMedID: 25408210

Title : Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype - Lane_2013_Alzheimers.Dement_9_e1
Author(s) : Lane RM , He Y
Ref : Alzheimers Dement , 9 :e1 , 2013
Abstract : Lane_2013_Alzheimers.Dement_9_e1
ESTHER : Lane_2013_Alzheimers.Dement_9_e1
PubMedSearch : Lane_2013_Alzheimers.Dement_9_e1
PubMedID: 22402324

Title : Targeting acetylcholinesterase and butyrylcholinesterase in dementia - Lane_2006_Int.J.Neuropsychopharmacol_9_101
Author(s) : Lane RM , Potkin SG , Enz A
Ref : Int J Neuropsychopharmacol , 9 :101 , 2006
Abstract : Lane_2006_Int.J.Neuropsychopharmacol_9_101
ESTHER : Lane_2006_Int.J.Neuropsychopharmacol_9_101
PubMedSearch : Lane_2006_Int.J.Neuropsychopharmacol_9_101
PubMedID: 16083515

Title : Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease - Lane_2005_J.Lipid.Res_46_949
Author(s) : Lane RM , Farlow MR
Ref : J Lipid Res , 46 :949 , 2005
Abstract : Lane_2005_J.Lipid.Res_46_949
ESTHER : Lane_2005_J.Lipid.Res_46_949
PubMedSearch : Lane_2005_J.Lipid.Res_46_949
PubMedID: 15716586

Title : Acetylcholinesterase and its inhibition in Alzheimer disease - Lane_2004_Clin.Neuropharmacol_27_141
Author(s) : Lane RM , Kivipelto M , Greig NH
Ref : Clinical Neuropharmacology , 27 :141 , 2004
Abstract : Lane_2004_Clin.Neuropharmacol_27_141
ESTHER : Lane_2004_Clin.Neuropharmacol_27_141
PubMedSearch : Lane_2004_Clin.Neuropharmacol_27_141
PubMedID: 15190239